GLP-1 Weight Loss, BMI & BMR Guides

Cannabis and GLP-1 both act on appetite and the gut. The interaction risks — gastroparesis, nausea, blunted weight loss — and what users report.

GLP-1s slow gastric emptying — retained food raises aspiration risk under sedation. When to stop, prep adjustments, and official guidance.

No direct interaction — but caffeine affects nausea, hydration, and appetite on GLP-1. Coffee, energy drinks, and your medication.

Users report spontaneously losing interest in cigarettes on GLP-1 — and early research backs it up. Nicotine, vaping, Zyn, and the cessation evidence.

Eli Lilly's dual GLP-1/glucagon agonist showing ~20% weight loss in phase 3 trials. Mechanism, results vs Zepbound, side effects, and approval timeline.

Millions take both ADHD stimulants and GLP-1s. The real interaction picture: absorption, appetite stacking, heart rate, and what prescribers watch.

Bupropion is already half of the weight-loss drug Contrave — so how does it combine with GLP-1? Safety, appetite stacking, and what prescribers watch.

Rapid weight loss on GLP-1 raises gallstone risk — it's on the label. Who's at risk, the warning signs, prevention, and when it's an emergency.

25-40% of GLP-1 weight loss can be lean mass, not fat. The protein targets, training protocols, and strategies that preserve muscle while you lose.

GLP-1s leave food in your stomach even after fasting — a real aspiration risk under anesthesia. The hold guidance and what to tell your surgical team.

TRT and GLP-1 are increasingly combined — testosterone may even protect against GLP-1 muscle loss. Interactions, benefits, and monitoring.

Hypothyroid patients can take GLP-1 — but weight loss changes levothyroxine needs and absorption timing matters. What to monitor and adjust.